Prabha Raghavan
Articles By Prabha Raghavan
‘Mega shopping festival’ may boost ‘Brand India’, but competing on global scale vital
FIEO president Sharad Kumar Saraf said such mega shopping festivals will not only boost exports but also help in creating value for “Brand India products from labour-intensive sectors”.
Explained: India’s mega shopping festivals: What is being planned and what is the impact?
The festival is expected to follow the model of Dubai's annual shopping festival, which is famous for the heavy discounts offered by retailers in the city on popular brands across sectors.
Site decided, Govt clears mega solar project in Leh and Kargil
The first package was to be set up in the areas tentatively identified in Zanskar sub-division and Taisuru block of Kargil district.
US FDA tests find salmonella in MDH sambar masala, three lots recalled
Salmonella is a bacteria that causes salmonellosis, a common food borne illness with symptoms like diarrhea, abdominal cramps and fever.
RK Singh interview: ‘You cannot be a developed country with a power sector that has load shedding’
The minister stressed on the renewed focus by the government to resolve problems of legacy dues to these gencos and make the downstream sectors more viable.
Oxytocin ban: Supreme Court raises more questions, refers matter to larger bench
Health Ministry in April 2018 notified a ban on private firms from manufacturing and selling oxytocin.
Explained: What is Oxytocin and why does the govt want to ban its commercial use?
The health ministry in April 2018 notified a ban on private firms from manuacturing and selling oxytocin, stating that it wanted to restrict the responsibility of supplying the drug to a Karnataka-based public sector manufacturer to avoid its misuse in the veterinary field.
USFDA warns Emcure Pharma for ‘failing’ to ‘adequately investigate’ injection sterility issues
The regulator has pointed out that Emcure “failed” to “adequately investigate” these sterility failures, adding that this is not the first time it uncovered such findings at the firm’s facility.
BP drug complaints: Lantech Pharma gets USFDA warning
The US Food and Drug Administration has issued a warning letter to Hyderabad-based Lantech Pharmaceuticals over its failure to investigate quality complaints related to the drug.
Drug regulator flags Piramal’s Supradyn, KAPL’s painkiller as ‘not of standard quality’
Central Drugs Standard Control Organisation this month labelled these batches as “not of standard quality” for failing tests conducted in July.
NHPC ‘hopeful’ of recovering over Rs 1,000 crore in dues from J&K power development PSU
NHPC Ltd, which currently operates eight hydropower projects in J&K, has entered into agreements with JKSPDC and the Jammu and Kashmir Power Development Department (JKPDD) to execute projects like the Ratle Hydroelectric Project, which has a capacity of 850 MW.
Hydropower need of the hour… want projects with no baggage: NHPC Chairman
NHPC Ltd Chairman and Managing Director Balraj Joshi tells The Indian Express that the company is also looking at devising some kind of mechanism to take over stranded private projects.
Trade Ban: Pakistan’s textile, pharma sectors to take a hit, $1 billion Indian inputs among casualties
India is not expected to face any negative impact from the suspension of trade as its imports from Pakistan are valued at less than a fourth of its total exports to the country.
E-Commerce: Transparency on details of sellers among key features of draft guidelines
The e-Commerce Guidelines for Consumer Protection 2019 will be applicable on all business-to-consumer (B2C) e-commerce platforms, according to the Department of Consumer Affairs, which has sought feedback from stakeholders by September 16.
To ensure authenticity, APIs of drugs may soon get track-and-trace codes
In 2015, DTAB had deliberated a proposal for mandatory bar coding at various levels of drug packaging to track their movement.
Sector scan: Sun Pharma set to shut down part of Vadodara R&D unit, 80 staff may lose jobs
In a letter to employees about the move, parts of which The Indian Express has viewed, Sun Pharmaceutical has announced it will shut down its Tandalja and Akota CPUs, part of the company’s Vadodara Research and Development (R&D) unit.
Locked in litigation on e-cigarettes, vapes ban, Health Ministry seeks opinion of Law Ministry
A senior official confirmed banning ENDS is part of the Health Ministry’s 100-day agenda, but another said it is holding off on implementing DTAB’s recommendations to clear legal hurdles.
WIPO Director General Francis Gurry: ‘In India, govt is main R&D investor… push from industry needed’
With the country now setting its sights on the top 25 ranks, WIPO Director General Francis Gurry identifies the measures it may have to take, and how the changing trajectory of trade and innovation will impact the global intellectual property framework.
New essential medicines’ list to have wider scope
Not all products in the list of essential medicines may come under price control.
Piyush Goyal holds ‘marathon’ of consultations with industry players ahead of RCEP meet
Goyal held a "marathon" of meetings with representatives of "all" sectors, including gems and jewellery, steel, copper, aluminum, zinc, chemicals, pharmaceuticals, plastics, rubber, leather, textile, apparel, auto, electronics and engineering products, according to them.
